Latest Form 4 insider transactions
NASDAQ
TALK
Talkspace, INCLiat Benzur, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCMadhu Pawar, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCJacqueline E Yeaney, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCErez Shachar, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NYSE
Michael Walter Neff, Chief Operating Officer of Bank of N.T. Butterfield & Son Ltd, sold 5,500 shares of common stock on August 14, 2026 for $63.66 per share.
NYSE
Dylan Hixon, a Director of Energy Vault Holdings, Inc., purchased 85,518 shares of common stock on August 14, 2026.
NASDAQ
TALK
Talkspace, INCDouglas L Braunstein, a Director and 10% owner of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCJohn Charles Reilly, Chief Legal Officer, Secretary of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCMichael E Hansen, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
TALK
Talkspace, INCCurtis Warfield, a Director of Talkspace, Inc., reported multiple transactions in common stock on August 17, 2026.
AMEX
CVM
Cel Sci CORPRobert Eugene Watson, a Director of Cel Sci Corp, received 110,000 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPBruno Jean-Marie Baillavoine, a Director of Cel Sci Corp, received 110,000 shares of common stock on August 14, 2026.
NASDAQ
Clifton Dameron, SVP, GC & Corporate Secretary of Willis Lease Finance Corp, sold 3,535 shares of common stock on August 14, 2026 for $56.83 per share.
AMEX
CVM
Cel Sci CORPJohn Cipriano, Senior Vice President of Cel Sci Corp, received 80,000 shares of common stock on August 14, 2026.
NASDAQ
Patrick Auletta V, a Director of Park Ohio Holdings Corp, received 59 shares of common stock on August 14, 2026.
NASDAQ
Dan T Moore Iii, a Director of Park Ohio Holdings Corp, received 27 shares of common stock on August 14, 2026.
NASDAQ
Andrew C Clarke, a Director of Park Ohio Holdings Corp, received 8 shares of common stock on August 14, 2026.
NASDAQ
John D Grampa, a Director of Park Ohio Holdings Corp, received 93 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPEyal Talor, Chief Scientific Officer of Cel Sci Corp, received 250,000 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPForm 4: Cel Sci CFO Receives Stock Grant
Patricia B Prichep, Chief Financial Officer of Cel Sci Corp, received 225,000 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPForm 4: Cel Sci CEO Receives Stock Grant
Geert R Kersten, Chief Executive Officer and a Director of Cel Sci Corp, received 300,000 shares of common stock on August 14, 2026.
NASDAQ
Franky Minnifield, a Director of Community Trust Bancorp Inc /Ky/, sold 3,900 shares of common stock on August 14, 2026 for $78.85 per share.
NYSE
AFL
Aflac INCForm 4: Aflac Insider Sells Shares
Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on August 13, 2026.
AMEX
Margaret Knight, a Director of Exodus Movement, Inc., sold 135 shares of common stock on August 3, 2026 for $5.11 per share.
NYSE
SMWB
Similarweb LTDForm 4: Similarweb CEO Sells Shares
Or Offer, Chief Executive Officer of Similarweb Ltd., sold 709,597 shares of common stock on August 13, 2026.
NASDAQ
NYAX
Nayax LTDForm 4: Nayax Director Sells Shares
Eran Havshush, a Director of Nayax Ltd., sold 20 shares of common stock on August 13, 2026 for $52.61 per share.
NASDAQ
Fulcrum Therapeutics and Slate Medicines are merging in an all-stock transaction, aiming to create a well-capitalized migraine-focused biotech company with a projected cash runway into 2029.
AMEX
HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.
HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.
NASDAQ
Fulcrum Therapeutics and Slate Medicines announce a merger agreement, combining forces to advance Slate's migraine therapeutics pipeline, supported by a $245 million financing.